Annual Report and Accounts and AGM

7 October 2015

Clinigen Group plc

Annual Report and Accounts and AGM

Clinigen Group plc (AIM: CLIN, 'Clinigen', or the 'Group'), the global specialty pharmaceuticals business, announces that its annual report and accounts for the year ended 30 June 2015 is now available on the Group's website at www.clinigengroup.com. 

Copies of the Annual Report and Accounts were posted to shareholders on 2 October 2015.

The Group will hold its Annual General Meeting ("AGM") on 27 October 2015 at 10.00am at Instinctif Partners' offices, 65 Gresham Street, London EC2V 7NQ. Peter George, Group Chief Executive Officer, and Shaun Chilton, Group Deputy Chief Executive Officer, will give a presentation at the AGM. The slides will be made available on the Group's website after the meeting. No new material information will be provided.

- Ends -

About Clinigen Group

Clinigen Group is a global pharmaceutical and services company with a unique combination of businesses dedicated to delivering the right drug to the right patient at the right time. The Group consists of four synergistic businesses that provide medicines to patients with unmet medical need; through Clinigen CTS we manage the supply of commercial medicines for clinical trials, through Idis Managed Access we run early access programs for our own and other companies' portfolios, our Idis Global Access team works directly with healthcare providers to enable ethical compliant access to unlicensed medicines, and through Clinigen SP, we market our own portfolio of niche commercial products.

We are global leaders in ethically sourcing and supplying unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet need.

For more information, please visit www.clinigengroup.com.

Contact Details